Key Factors To Evaluate When Considering BYOD Clinical Trials
Using eCOA to Capture Clinical Study Data
When making the switch from paper-based to electronic capture of Clinical Outcome Assessments (COA) data, there are a number of options that study teams must consider in terms of how the data is collected.
Traditionally, electronic Clinical Outcomes Assessments (eCOA) data has been captured via provisioned devices (i.e., devices that have been provided to participants). However, over recent years, there has been a rise in the number of sponsors and CROs interested in running Bring Your Own Device (BYOD) clinical trials due to the array of perceived benefits, as well as the increase in availability of technology.
While the move toward BYOD promises many advantages, including increased device familiarity, cost savings on devices, and improved accessibility for patients, it is certainly not a one-size-fits-all approach. There are a number of key considerations that sponsors and CROs should be reviewing in order to evaluate the benefits of the methodology against the unique needs of each of their studies before deciding whether it is the most appropriate approach. As this eBook will make clear, the key to successful eCOA implementation of any kind (BYOD or provisioned) is through a focus on delivering a quality solution that meets the unique needs of patients and study teams.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.